Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Co. stock logo
BSX
Boston Scientific
$75.63
+1.7%
$70.61
$48.35
$76.25
$110.96B0.776.49 million shs4.79 million shs
The Cigna Group stock logo
CI
The Cigna Group
$332.61
-1.5%
$350.99
$240.50
$365.71
$94.48B0.571.59 million shs1.31 million shs
Centene Co. stock logo
CNC
Centene
$74.63
-3.5%
$75.47
$60.83
$81.42
$39.83B0.413.17 million shs4.02 million shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$521.41
-4.1%
$523.69
$412.00
$550.34
$121.19B0.791.01 million shs1.53 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.00%+1.31%+3.42%+13.44%+48.12%
The Cigna Group stock logo
CI
The Cigna Group
0.00%-1.80%-6.15%-2.83%+36.26%
Centene Co. stock logo
CNC
Centene
0.00%-4.39%+0.85%-6.98%+18.99%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.00%-4.80%-2.95%+2.92%+16.94%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Boston Scientific Co. stock logo
BSX
Boston Scientific
4.3507 of 5 stars
2.53.00.04.22.72.52.5
The Cigna Group stock logo
CI
The Cigna Group
4.9254 of 5 stars
2.55.02.54.22.82.53.1
Centene Co. stock logo
CNC
Centene
4.8041 of 5 stars
3.34.00.03.92.12.53.1
Elevance Health, Inc. stock logo
ELV
Elevance Health
4.4649 of 5 stars
3.53.04.20.02.82.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Co. stock logo
BSX
Boston Scientific
2.95
Moderate Buy$75.41-0.29% Downside
The Cigna Group stock logo
CI
The Cigna Group
2.92
Moderate Buy$366.1410.08% Upside
Centene Co. stock logo
CNC
Centene
2.50
Moderate Buy$85.2314.20% Upside
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.92
Moderate Buy$587.4212.66% Upside

Current Analyst Ratings

Latest CI, ELV, CNC, and BSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$85.00 ➝ $87.00
5/15/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$85.00 ➝ $90.00
5/3/2024
The Cigna Group stock logo
CI
The Cigna Group
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$384.00 ➝ $400.00
5/3/2024
The Cigna Group stock logo
CI
The Cigna Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$370.00 ➝ $400.00
5/2/2024
Centene Co. stock logo
CNC
Centene
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$101.00 ➝ $104.00
4/30/2024
Centene Co. stock logo
CNC
Centene
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$81.00 ➝ $82.00
4/29/2024
Centene Co. stock logo
CNC
Centene
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$110.00 ➝ $110.00
4/26/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$70.00 ➝ $78.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$79.00 ➝ $85.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$72.00 ➝ $82.00
4/25/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$63.00 ➝ $73.00
(Data available from 5/27/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Co. stock logo
BSX
Boston Scientific
$14.24B7.79$2.90 per share26.05$13.33 per share5.67
The Cigna Group stock logo
CI
The Cigna Group
$195.27B0.48$35.84 per share9.28$158.03 per share2.10
Centene Co. stock logo
CNC
Centene
$155.52B0.26$9.25 per share8.07$48.55 per share1.54
Elevance Health, Inc. stock logo
ELV
Elevance Health
$171.34B0.71$41.25 per share12.64$169.07 per share3.08

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Co. stock logo
BSX
Boston Scientific
$1.59B$1.1963.5528.872.6012.06%16.39%9.08%7/25/2024 (Estimated)
The Cigna Group stock logo
CI
The Cigna Group
$5.16B$12.1827.3110.421.011.76%17.24%5.09%8/1/2024 (Estimated)
Centene Co. stock logo
CNC
Centene
$2.70B$5.0314.849.870.961.76%14.19%4.42%7/26/2024 (Estimated)
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.99B$26.4619.7112.531.153.64%20.62%7.35%7/17/2024 (Estimated)

Latest CI, ELV, CNC, and BSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024Q1 2024
The Cigna Group stock logo
CI
The Cigna Group
$6.17$6.47+$0.30$13.91$56.59 billion$57.25 billion    
4/26/2024Q1 24
Centene Co. stock logo
CNC
Centene
$2.09$2.26+$0.17$2.36$36.43 billion$40.41 billion    
4/24/2024Q1 2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
$0.51$0.56+$0.05$0.79$3.68 billion$3.86 billion
4/18/2024Q1 2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.54$10.64+$0.10$11.69$42.49 billion$42.27 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Co. stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
The Cigna Group stock logo
CI
The Cigna Group
$5.601.68%+397.32%45.98%4 Years
Centene Co. stock logo
CNC
Centene
N/AN/AN/AN/AN/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.521.25%+15.93%24.64%13 Years

Latest CI, ELV, CNC, and BSX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/16/2024
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.631.2%6/10/20246/10/20246/25/2024
4/24/2024
The Cigna Group stock logo
CI
The Cigna Group
quarterly$1.401.59%6/4/20246/4/20246/20/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.47
1.66
1.14
The Cigna Group stock logo
CI
The Cigna Group
0.75
0.71
0.71
Centene Co. stock logo
CNC
Centene
0.66
1.17
1.17
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.54
1.37
1.37

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Co. stock logo
BSX
Boston Scientific
89.07%
The Cigna Group stock logo
CI
The Cigna Group
86.99%
Centene Co. stock logo
CNC
Centene
93.63%
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%

Insider Ownership

CompanyInsider Ownership
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.50%
The Cigna Group stock logo
CI
The Cigna Group
0.70%
Centene Co. stock logo
CNC
Centene
0.33%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.29%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Co. stock logo
BSX
Boston Scientific
48,0001.47 billion1.46 billionOptionable
The Cigna Group stock logo
CI
The Cigna Group
72,500284.07 million282.09 millionOptionable
Centene Co. stock logo
CNC
Centene
67,700533.66 million532.11 millionOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
104,900232.42 million231.74 millionOptionable

CI, ELV, CNC, and BSX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Boston Scientific logo

Boston Scientific

NYSE:BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
The Cigna Group logo

The Cigna Group

NYSE:CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Centene logo

Centene

NYSE:CNC
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Elevance Health logo

Elevance Health

NYSE:ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.